U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07001800) titled 'A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis' on May 13.
Brief Summary: The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.
Study Start Date: June 17
Study Type: INTERVENTIONAL
Condition:
Moderate Aortic Valve Stenosis
Intervention:
DRUG: Ataciguat
Ataciguat will be administrated daily for up to 156 weeks
DRUG: Placebo
Placebo will be administrated daily for up to 156 weeks
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Kardigan, Inc.
Published by HT Digital Content Services with permis...